TH78150A - Solid preparation - Google Patents
Solid preparationInfo
- Publication number
- TH78150A TH78150A TH401004195A TH0401004195A TH78150A TH 78150 A TH78150 A TH 78150A TH 401004195 A TH401004195 A TH 401004195A TH 0401004195 A TH0401004195 A TH 0401004195A TH 78150 A TH78150 A TH 78150A
- Authority
- TH
- Thailand
- Prior art keywords
- solid preparation
- insulin
- acid ester
- preparation according
- secretagogue
- Prior art date
Links
- 239000007787 solid Substances 0.000 title claims abstract 7
- 239000003814 drug Substances 0.000 claims abstract 4
- -1 fatty acid ester Chemical class 0.000 claims abstract 3
- 229940079593 drug Drugs 0.000 claims abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 102000004877 Insulin Human genes 0.000 claims 2
- 108090001061 Insulin Proteins 0.000 claims 2
- 229940100389 Sulfonylurea Drugs 0.000 claims 2
- 229940125396 insulin Drugs 0.000 claims 2
- 230000003914 insulin secretion Effects 0.000 claims 2
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 claims 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- 229930040373 Paraformaldehyde Natural products 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 229920006324 polyoxymethylene Polymers 0.000 claims 1
- 229940122199 Insulin secretagogue Drugs 0.000 abstract 4
- 229940122355 Insulin sensitizer Drugs 0.000 abstract 4
- 229920001214 Polysorbate 60 Polymers 0.000 abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 2
- 229930195729 fatty acid Natural products 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 abstract 2
- 229940124597 therapeutic agent Drugs 0.000 abstract 2
Abstract
DC60 (03/10/57) ให้สารเตรียมชนิดแข็งที่มีประโยชน์เป็นสารรักษาเบาหวานหรือที่คล้ายคลึงกัน และมีคุณสมบัติการละลายของสารทำให้ไวต่ออินซูลินและสารเร่งการหลั่งอินซูลินที่ดีเยี่ยม, ซึ่งประกอบรวมด้วยสารทำให้ไวต่ออินซูลิน, สารเร่งการหลั่งอินซูลินและพอลิออกซิเอธิลีน ซอร์บิแทน แฟทที แอซิด เอสเทอร์ ให้ยาปรุงสำเร็จชนิดแข็งที่มีประโยชน์เป็นสารรักษาเบาหวานหรือที่คล้ายคลึงกัน และมีคุณสมบัติการละลายของสารทำให้ไวต่ออินซูลินและสารเร่งการหลั่งอินซูลินที่ดีเยี่ยม, ซึ่งประกอบรวมด้วยสารทำให้ไวต่ออินซูลิน, สารเร่งการหลั่งอินซูลินและพอลิออกซิเอธิลีน ซอร์บิแทน แฟทที แอซิด เอสเทอร์ สิทธิบัตรยาDC60 (03/10/57) Provides a solid preparation useful as a therapeutic agent or similar and has excellent solubility properties of insulin sensitizer and insulin secretagogue, comprising insulin sensitizer, insulin secretagogue and polyoxyethylene sorbitan fatty acid ester. Provides a solid preparation useful as a therapeutic agent or similar and has excellent solubility properties of insulin sensitizer and insulin secretagogue, comprising insulin sensitizer, insulin secretagogue and polyoxyethylene sorbitan fatty acid ester. Patented drug.
Claims (5)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH78150A true TH78150A (en) | 2006-06-22 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1799865A4 (en) | METHODS OF ADMINISTERING ILOPERIDONE | |
| WO2005065646A3 (en) | Novel drug compositions and dosage forms | |
| DK1740154T3 (en) | Insulin compositions with improved absorption | |
| EA200500399A1 (en) | NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | |
| EA200301165A1 (en) | Drug on the basis of oxycodone | |
| MY147310A (en) | A solid pharmaceutical composition containing 2-ethoxy-1-{ [2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl) biphenyl-4-yl]methyl}-1h-benzimidazole-7-carboxylic acid or a salt thereof, a fat and oil-like substace having low melting point and a low viscosity binder | |
| IL189375A (en) | 1-heterocyclylsulfonyl-3-aminomethyl, 5-(hetero)aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments | |
| TN2009000317A1 (en) | Solid preparation comprising alogliptin and pioglitazone | |
| EA200601747A1 (en) | THREE (CYCLO) SUBSTITUTED AMIDA COMPOUNDS | |
| ITFI20050031A1 (en) | A PHARMACEUTICAL COMPOSITION TO PREVENT THE AGING AND THE RISING OF VASCULAR, NEOPLASTIC, CUTANEOUS AND PILIFEROUS DISEASES | |
| WO2010005980A8 (en) | Tacrolimus for improved treatment of transplant patients | |
| DK1678162T3 (en) | Β-glycoprotein inhibitor, process for its preparation and pharmaceutical composition comprising it | |
| CA2540225A1 (en) | Solid preparation of pioglitazone, glimepiride and a polyoxyethylene sorbitan fatty acid ester | |
| NO20076053L (en) | Pyrazole pyrimidine derivative for the treatment and prevention of liver disease | |
| MA28862B1 (en) | PHARMACEUTICAL COMPOSITION IN THE FORM OF A GASTRIC RESISTANCE COMPRESSOR CONTAINING AN ACTIVE INGREDIENT | |
| DE502005010427D1 (en) | PHYSIOLOGICAL ACTIVE COMPOSITION AGAINST DIABETES | |
| WO2004091591A3 (en) | Nutritional or therapeutic composition containing the compound oleuropeine or one of the derivatives thereof | |
| WO2005065648A3 (en) | Novel drug compositions and dosage forms of topiramate | |
| EA200500764A1 (en) | PHARMACEUTICAL COMPOSITIONS AND MEDICAL FORMS FOR TRANSBUCCAL AND SUBLINGUAL DELIVERY TIZANIDINE AND METHODS OF INTRODUCTION TIZANIDINE SUBLINGUAL OR TRANSBUCKAL | |
| TH78150A (en) | Solid preparation | |
| TN2010000058A1 (en) | AROMATIZED THERAPEUTIC COMPOSITION BASED ON CLAY | |
| DE50105710D1 (en) | PHARMACEUTICAL BRAMULAR FORMULATION CONTAINING RAMIPRIL | |
| DE602004022515D1 (en) | FENOFIBRATE TABLET AND METHOD OF PREPARING THEREOF | |
| MX2010008285A (en) | Galenic form for the oral transmucosal delivery of triptans. | |
| IS8428A (en) | Infusion containing (2R) -2-propyl octanoic acid as the active ingredient |